Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

321 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of high-dose cytarabine MEAM therapy and other treatments for auto-peripheral blood stem cell transplantation: A retrospective comparative study.
Yui S, Wakita S, Nagata Y, Kuribayashi Y, Asayama T, Fujiwara Y, Sakaguchi M, Yamanaka S, Marumo A, Omori I, Kinoshita R, Onai D, Sunakawa M, Kaito Y, Inai K, Tokura T, Takeyoshi A, Yasuda S, Honma S, Nakayama K, Hirakawa T, Arai K, Kitano T, Okamoto M, Inokuchi K, Yamaguchi H. Yui S, et al. Among authors: inai k. Asia Pac J Clin Oncol. 2023 Feb;19(1):136-148. doi: 10.1111/ajco.13780. Epub 2022 May 22. Asia Pac J Clin Oncol. 2023. PMID: 35599446
Importance of prognostic stratification via gene mutation analysis in elderly patients with acute myelogenous leukemia.
Fujiwara Y, Yamaguchi H, Yui S, Tokura T, Inai K, Onai D, Omori I, Marumo A, Yamanaka S, Sakaguchi M, Terada K, Nakagome S, Arai K, Kitano T, Okabe M, Okamoto M, Tamai H, Nakayama K, Tajika K, Wakita S, Inokuchi K. Fujiwara Y, et al. Among authors: inai k. Int J Lab Hematol. 2019 Aug;41(4):461-471. doi: 10.1111/ijlh.13025. Epub 2019 Apr 10. Int J Lab Hematol. 2019. PMID: 30970181 Clinical Trial.
Risk Factors for Acute Kidney Injury and Chronic Kidney Disease following Allogeneic Hematopoietic Stem Cell Transplantation for Hematopoietic Malignancies.
Sakaguchi M, Nakayama K, Yamaguchi H, Mii A, Shimizu A, Inai K, Onai D, Marumo A, Omori I, Yamanaka S, Fujiwara Y, Fukunaga K, Ryotokuji T, Hirakawa T, Okabe M, Tamai H, Okamoto M, Wakita S, Yui S, Tsuruoka S, Inokuchi K. Sakaguchi M, et al. Among authors: inai k. Acta Haematol. 2020;143(5):452-464. doi: 10.1159/000504354. Epub 2019 Dec 10. Acta Haematol. 2020. PMID: 31822013
Outcomes of Patients with Early Hyperbilirubinemia after Allogeneic Hematopoietic Stem Cell Transplantation.
Omori I, Yamaguchi H, Hirakawa T, Inai K, Onai D, Marumo A, Yamanaka S, Sakaguchi M, Fujiwara Y, Wakita S, Okamoto M, Tamai H, Nakayama K, Yui S, Inokuchi K. Omori I, et al. Among authors: inai k. J Nippon Med Sch. 2020 Jul 13;87(3):142-152. doi: 10.1272/jnms.JNMS.2020_87-404. Epub 2020 Jan 31. J Nippon Med Sch. 2020. PMID: 32009070 Free article.
Presence of Promyelocytes in Peripheral Blood as a Novel Predictor of Optimal Timing for Single-Step Peripheral Blood Stem Cell Collection.
Marumo A, Yamaguchi H, Hirakawa T, Inai K, Onai D, Omori I, Yamanaka S, Fujiwara Y, Sakaguchi M, Wakita S, Okamoto M, Yui S, Inokuchi K. Marumo A, et al. Among authors: inai k. J Nippon Med Sch. 2021 Mar 11;88(1):45-53. doi: 10.1272/jnms.JNMS.2021_88-104. Epub 2020 Mar 31. J Nippon Med Sch. 2021. PMID: 32238739 Free article.
Elevation of Urinary Liver-Type Fatty Acid-Binding Protein Is a Harbinger of Poor Patient Prognosis after Allogeneic Stem Cell Transplantation.
Shingai N, Ota A, Kato K, Kondo K, Sadaga Y, Kato C, Sakai S, Kambara Y, Nabe Y, Asano K, Teshima K, Kurihara K, Ouchi F, Fujiwara H, Shimabukuro M, Inai K, Jinguji A, Toya T, Shimizu H, Najima Y, Kobayashi T, Sugaya T, Ando M, Doki N. Shingai N, et al. Among authors: inai k. Transplant Cell Ther. 2024 Jan;30(1):121.e1-121.e8. doi: 10.1016/j.jtct.2023.10.003. Epub 2023 Oct 7. Transplant Cell Ther. 2024. PMID: 37813188
[FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with PTPN11 mutation at relapse].
Kurihara K, Sadato D, Najima Y, Hirama C, Haraguchi K, Kato K, Kondo K, Sadaga Y, Kato C, Sakai S, Kambara Y, Nabe Y, Teshima K, Asano K, Jinguji A, Shimabukuro M, Ouchi F, Inai K, Koi S, Shingai N, Toya T, Shimizu H, Kobayashi T, Oboki K, Harada H, Okuyama Y, Harada Y, Doki N. Kurihara K, et al. Among authors: inai k. Rinsho Ketsueki. 2024;65(2):63-68. doi: 10.11406/rinketsu.65.63. Rinsho Ketsueki. 2024. PMID: 38447999 Japanese.
Identification of Prostaglandin I2 Synthase Rare Variants in Patients With Williams Syndrome and Severe Peripheral Pulmonary Stenosis.
Chida-Nagai A, Akagawa H, Sawai S, Ma YJ, Yakuwa S, Muneuchi J, Yasuda K, Yamazawa H, Yamamoto T, Takakuwa E, Tomaru U, Furutani Y, Kato T, Harada G, Inai K, Nakanishi T, Manabe A, Takeda A, Jing ZC. Chida-Nagai A, et al. Among authors: inai k. J Am Heart Assoc. 2024 May 7;13(9):e032872. doi: 10.1161/JAHA.123.032872. Epub 2024 Apr 19. J Am Heart Assoc. 2024. PMID: 38639351 Free article.
Correction: The c.1617del variant of TMEM260 is identified as the most frequent single gene determinant for Japanese patients with a specific type of congenital heart disease.
Inoue T, Takase R, Uchida K, Kodo K, Suda K, Watanabe Y, Yoshiura KI, Kunimatsu M, Ishizaki R, Azuma K, Inai K, Muneuchi J, Furutani Y, Akagawa H, Yamagishi H. Inoue T, et al. Among authors: inai k. J Hum Genet. 2024 May;69(5):223. doi: 10.1038/s10038-024-01238-5. J Hum Genet. 2024. PMID: 38459226 No abstract available.
321 results